PharmaTher Files FDA Pre-IND Meeting Request and Briefing Package For KETABET™...

Field Trip Health Ltd. Announces Completion of DMPK Studies, Engineering Batch...

PT248 – Pierre Bouchard – Somatic Therapy, Trauma, and the Nervous...

Psychedelic Research Bulletin: May 2021

Psychedelic Bulletin: MindMed CEO Steps Down; Atai Targets $2.3bn Valuation

Filament Announces First GMP Batch of Pharmaceutical Grade Natural Psilocybin

PTSF63 – The Media and Legalization, Joints for Jabs, and 40,000...

Atai Targets $2.3bn Valuation in Nasdaq IPO

atai Life Sciences Announces Launch of Initial Public Offering

LSD and the Anarchic Brain

Load more